Mavenclad (cladribine) and Kesimpta (ofatumumab) are both medications used for treating Multiple Sclerosis (MS), but they serve different purposes and work in different ways. Neither of these medications is specifically designed to provide energy for MS patients, but they target the disease process itself. Managing Fatigue in Secondary Progressive MS (SPMS): Both medications can help … Continue reading Which Medication Provides Energy For Secondary Ms, Mavenclad Or Kesimpta